Askesis Development Group

1
Buprenorphine Treatment Care Coordination
Indications and Options James Schuster, MD,
MBA Chief Medical Officer Community Care

2
Care Coordination and Collaboration are critical

• Inherent part of opiate addiction treatment
• Frequent co-morbid disorders
• Support Members Recovery

3
Key Part of Addiction Treatment

• Required counseling in methadone maintenance
  programs. Pharmacotherapy alone is rarely
  adequate in addiction treatment.
• Included in all guidelines for buprenorphine
  treatment. Programs typically require concurrent
  treatment as well as participation in self-help
  programs.
• Eventual abstinence is the typical goal with
  buprenorphine

4
Treatment of Co-Morbid disorders

• Often require concurrent medication treatment
• Screening for co-occurring disorders is critical
• People with concurrent disorders do well with
  appropriate treatment
• Most frequent are
• Other substance abuse disorders
• Depressive disorders
• PTSD
• Substance induced Psychiatric disorders
• Antisocial and Borderline Personality disorders

5
Support of Members Recovery

• Recovery from addiction
• Recovery from the impact of addictions
• Work
• Family
• Spiritual
• Other Personal Growth

6
Development of Concurrent Resources

• Best coordination is to have concurrent
  behavioral treatment on site as part of your
  organization
• Second best is on site treatment from another
  provider
• Third option is well coordinated treatment
• Managed care organizations can assist with
  identifying organizations for coordination and
  with referrals